Showing results (21-30 of 91) with videos related to
Sort By:
Pageof 10
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 12, 2008
Verrucoid lesions of mitral valve in a dog with features of inflammatory myofibroblastic tumorMassimiliano Tursi, Luca Garofalo, Maruska Muscio, et al.International Journal of Molecular Sciences|December 17, 2024
Technology Innovation for Discovering Renal Autoantibodies in Autoimmune ConditionsMaurizio Bruschi, Giovanni Candiano, Andrea Petretto, et al.Cardiovascular Diagnosis and Therapy|September 3, 2015
Preclinical evaluation of a novel abluminal surface coated sirolimus eluting stent with biodegradable polymer matrixPrakash Sojitra, Manish Doshi, Marco Galloni, et al.Pediatric Nephrology (Berlin, Germany)|April 2, 2020
Rituximab for very low dose steroid-dependent nephrotic syndrome in children: a randomized controlled studyPietro Ravani, Francesca Lugani, Isabella Pisani, et al.Journal of Proteomics|February 5, 2013
Proteomic analysis of podocyte exosome-enriched fraction from normal human urineMarco Prunotto, Annarita Farina, Lydie Lane, et al.Autoimmunity Reviews|October 31, 2021
Anti-alpha enolase multi-antibody specificity in human diseases. Clinical significance and molecular mechanismsAndrea Angeletti, Paola Migliorini, Maurizio Bruschi, et al.The Journal of Pathology|May 10, 2012
Epithelial-mesenchymal crosstalk alteration in kidney fibrosisMarco Prunotto, David C Budd, Giulio Gabbiani, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 2, 2011
Cre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulationClaudio Moretti, Vasco Lolli, Giovanni Perona, et al.Journal of Proteomics|June 7, 2011
Renal fibrosis and proteomics: current knowledge and still key open questions for proteomic investigationMarco Prunotto, Gianmarco Ghiggeri, Maurizio Bruschi, et al.Cancer Research|January 1, 2016
Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1Fatima Ali-Rahmani, David J FitzGerald, Scott Martin, et al.Pageof 10